Elevated Serum Beta‐Trace Protein Levels are Associated With the Presence of Atrial Fibrillation in Hypertension Patients

Elevated Serum Beta‐Trace Protein Levels are Associated With the Presence of Atrial Fibrillation in Hypertension Patients

Beta‐trace protein (BTP) has emerged as a novel biomarker of cardiovascular risk. In this study, the authors aimed to assess the relationship between BTP levels and presence of atrial fibrillation in patients who had controlled hypertension (HTN) and normal renal function. A total of 80 controlled H...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2016-05, Vol.18 (5), p.439-443
Hauptverfasser: Yalcin, Muhammed U., Gurses, Kadri M., Kocyigit, Duygu, Kesikli, Sacit A., Tokgozoglu, Lale, Guc, Dicle, Aytemir, Kudret, Ozer, Necla
Format: Artikel
Sprache:eng
Schlagworte:
Atrial Fibrillation - metabolism
Creatinine - blood
Cystatin C - blood
Female
Glomerular Filtration Rate
Humans
Hypertension - complications
Hypertension - metabolism
Intramolecular Oxidoreductases - blood
Lipocalins - blood
Male
Middle Aged
Odds Ratio
Original Paper
Original Papers
Risk Factors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Beta‐trace protein (BTP) has emerged as a novel biomarker of cardiovascular risk. In this study, the authors aimed to assess the relationship between BTP levels and presence of atrial fibrillation in patients who had controlled hypertension (HTN) and normal renal function. A total of 80 controlled HTN patients with paroxysmal atrial fibrillation (PAF) and 80 age‐ and sex‐matched controls with controlled HTN were enrolled. Serum BTP levels were measured by enzyme‐linked immunosorbent assay. BTP levels were found to be significantly higher in patients with PAF (P
ISSN:1524-6175
1751-7176
DOI:10.1111/jch.12703